🔴 Indaptus Therapeutics is trading 5.66% down today as risk-off sentiment weighs on markets

Indaptus Therapeutics is trading 5.66% down now at $0.94, with the decline appearing aligned with broader risk-off sentiment.

• Shares fell 6.54% to $1.00 on August 17, 2026.
• The S&P 500 is down 0.58% and the Nasdaq Composite is down 1.36%.
• Recent earnings highlighted the halted Decoy20 trial and strategic pivot; that report was released August 13. No new company-specific announcement was identified for August 18.